Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines in the United States. Its commercial products are reSET for the treatment of substance use ...
BOSTON--(BUSINESS WIRE)--Sandoz Inc., a division of Novartis, and Pear Therapeutics, Inc., the leader in prescription digital therapeutics, today announced that the U.S. Food and Drug Administration ...
Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines in the United States. Its commercial products are reSET for the treatment of substance use ...
A downtrend has been apparent in Pear Therapeutics, Inc. (PEAR) lately with too much selling pressure. The stock has declined 17.4% over the past four weeks. However, given the fact that it is now in ...
Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines, called prescription digital therapeutics (PDTs), rings the Nasdaq Closing Bell remotely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results